Skip to main content
. 2022 Jun 5;14(6):1202. doi: 10.3390/pharmaceutics14061202

Figure 5.

Figure 5

In vitro cytotoxicity of LipoIRI and BS−LipoIRI for BxPC3 pancreatic tumor cells.